About Pulse Biosciences Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.pulsebiosciences.com/
Frequently Asked Questions
What is the 52-week range for PLSE?
The 52-week high is $58.9 and the 52-week low is $12.56.
What is the P/E ratio for PLSE?
The P/E ratio data is currently unavailable.
What is the dividend yield for PLSE?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -94.42%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -6755.78%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 11.54.
Analyst Recommendation Trends
Wall Street analyst consensus for PLSE over the last few months:
Latest PLSE News
Pulse Biosciences: Promising Technology, But Hard To Justify Its Valuation
PLSEâs catheter data and rapid pivotal enrollment showcase that they have a healthy and promising business. I reiterate my âHoldâ on PLSE at these levels.
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
BTIG Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $70
BTIG analyst Marie Thibault initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $70.
Pulse Biosciences Files Prospectus Supplement For Up To $85M At-The-market Common Stock Offering Via Mizuho; Terminates TD Cowen Distribution Agreement On Sept 14, 2026 With $1M Unsold
On September 15, 2026, Pulse Biosciences, Inc. (the "Company") entered into an equity distribution agreement (the "Sales Agreement") with Mizuho Securities USA LLC ("Mizuho") as sales agent,
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
HAYWARD, Calif., September 15, 2026--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced two milestones in the PRECISE-BTN clinical study evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for the treatment of symptomatic benign thyroid nodules (BTNs). The first patient enrolled in the study completed the final 12-month follow-up visit in August at Sara
Pulse Biosciences Concludes 100 Patient Enrollment in PRECISE-BTN Study of nPulse Vybrance Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced two milestones in the PRECISE-BTN
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
Why Pulse Biosciences Stock Popped Today
The medical device maker now has a new bull touting its growth potential.
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Opus Genetics (NASDAQ:IRD) shares increased by 31.7% to $5.71 during Wednesday's regular session. The company's market cap stands at $361.0 million. bioAffinity Technologies (NASDAQ:BIAF) stock
Freedom Capital Markets Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $73
Freedom Capital Markets analyst Keith Hinton initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $73.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-01 | Teplitsky Liane Rae | +1,001 | $49.95 | $50,000 |
| 2026-08-31 | Teplitsky Liane Rae | +1,024 | $48.8 | $49,971 |
| 2026-08-28 | Teplitsky Liane Rae | +1,034 | $48.35 | $49,994 |
| 2026-08-26 | Teplitsky Liane Rae | +1,036 | $48.235 | $49,971 |
| 2026-08-08 | Teplitsky Liane Rae | +700,000 | - | - |
| 2026-08-08 | Teplitsky Liane Rae | +200,000 | - | - |
| 2026-06-11 | Soni Manmeet Singh | +30,000 | - | - |
| 2026-06-11 | Zanganeh Mahkam | +14,504 | - | - |
| 2026-06-11 | Zanganeh Mahkam | +30,000 | - | - |
| 2026-06-11 | Sainz Maria | +3,793 | - | - |
| 2026-06-11 | Sainz Maria | +30,000 | - | - |
| 2026-06-11 | van den Broek Richard | +8,423 | - | - |
| 2026-06-11 | van den Broek Richard | +30,000 | - | - |
| 2026-06-11 | DUGGAN ROBERT W | +12,495 | - | - |
| 2026-06-11 | DUGGAN ROBERT W | +30,000 | - | - |
| 2026-05-11 | DUGGAN ROBERT W | +660,233 | $19.69 | $12,999,988 |
| 2026-05-11 | LAVIOLETTE PAUL A | +15,000 | $19.69 | $295,350 |
| 2026-05-11 | LAVIOLETTE PAUL A | +15,000 | $19.69 | $295,350 |
| 2026-05-11 | DUGGAN ROBERT W | +660,233 | $19.69 | $12,999,988 |
| 2026-03-23 | UECKER DARRIN | +100,000 | - | - |
| 2026-02-18 | Danahy Kevin Patrick | -5,000 | - | - |
| 2026-02-18 | Danahy Kevin Patrick | -5,000 | $23.64 | $118,200 |
| 2026-02-18 | Danahy Kevin Patrick | +5,000 | $1.53 | $7,650 |
| 2026-02-17 | Danahy Kevin Patrick | -20,000 | - | - |
| 2026-02-17 | Danahy Kevin Patrick | -20,000 | $23.63 | $472,600 |
| 2026-02-17 | Danahy Kevin Patrick | +20,000 | $1.53 | $30,600 |
| 2026-02-13 | Danahy Kevin Patrick | -20,000 | - | - |
| 2026-02-13 | Danahy Kevin Patrick | -20,000 | $23.53 | $470,600 |
| 2026-02-13 | Danahy Kevin Patrick | +20,000 | $1.53 | $30,600 |
| 2026-02-12 | Danahy Kevin Patrick | -20,000 | - | - |
| 2026-02-12 | Danahy Kevin Patrick | -20,000 | $23.37 | $467,400 |
| 2026-02-12 | Danahy Kevin Patrick | +20,000 | $1.53 | $30,600 |
| 2026-02-11 | Danahy Kevin Patrick | -20,000 | - | - |
| 2026-02-11 | Danahy Kevin Patrick | -20,000 | $25.2 | $504,000 |
| 2026-02-11 | Danahy Kevin Patrick | +20,000 | $1.53 | $30,600 |
| 2026-02-10 | Danahy Kevin Patrick | -20,000 | - | - |
| 2026-02-10 | Danahy Kevin Patrick | -20,000 | $23.52 | $470,400 |
| 2026-02-10 | Danahy Kevin Patrick | +20,000 | $1.53 | $30,600 |
| 2026-02-09 | Danahy Kevin Patrick | -20,000 | - | - |
| 2026-02-09 | Danahy Kevin Patrick | -20,000 | $21.45 | $429,000 |
| 2026-02-09 | Danahy Kevin Patrick | +20,000 | $1.53 | $30,600 |
| 2026-02-05 | Sainz Maria | +3,104 | - | - |
| 2026-01-08 | Sainz Maria | +50,000 | - | - |